TITAN PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Titan Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Titan Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $47K.
  • Titan Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $1.01M, a 6.97% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $1.01M, a 6.97% increase from 2022.
  • Titan Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $947K, a 37.1% decline from 2021.
  • Titan Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.51M, a 21400% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.01M +$66K +6.97% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $947K -$558K -37.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.51M +$1.5M +21400% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $7K -$565K -98.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $572K -$985K -63.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $1.56M -$130K -7.71% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $1.69M +$648K +62.4% Jan 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
2016 $1.04M +$13K +1.27% Jan 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
2015 $1.03M +$483K +89% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $543K -$135K -19.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $678K -$1.9M -73.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $2.58M +$1.4M +119% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-31
2011 $1.18M +$444K +60.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-31
2010 $733K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.